Dragonfly Therapeutics
Business Services · Massachusetts, United States · 113 Employees
View Company Info for Free
About
Headquarters
35 Gatehouse Dr, Waltham, Massachusetts, 02451,...Phone Number
(617) 588-0086Website
www.dragonflytx.comRevenue
$8.4 MillionIndustry
Most Recent Scoops
Who is Dragonfly Therapeutics
Dragonfly Therapeutics Org Chart
Is Dragonfly Therapeutics your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Dragonfly Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Dragonfly Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Dragonfly Therapeutics
Product Launch: Get notified when Dragonfly Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Check if Dragonfly Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Dragonfly Therapeutics is spiking on competitors!
Dragonfly Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Dragonfly Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Dragonfly Therapeutics
Find 3 more new buyers
Compare Similar Companies to Dragonfly Therapeutics
Compare insights from companies similar to Dragonfly Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Dragonfly Therapeutics
Dragonfly Therapeutics Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Dragonfly Therapeutics Tech Stack
A closer look at the technologies used by Dragonfly Therapeutics
Most Recent Scoops
Dragonfly Therapeutics News & Media
Dragonfly Therapeutics, Inc. Announces Clinical Collaboration to Evaluate DF9001, an EGFR targeting TriNKET®, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors
DF9001 is currently being evaluated as a monotherapy for the treatment of Non-Small Cell Lung Cancer, Renal Cell Carcinoma and Head and Neck Squamous Cell Carcinoma. The clinical trial collaboration will focus on evaluating the investigational combination in second line Renal Cell...Dragonfly Therapeutics, Inc. Announces Clinical Collaboration to Evaluate DF9001, an EGFR targeting TriNKET®, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors
DF9001 is currently being evaluated as a monotherapy for the treatment of Non-Small Cell Lung Cancer, Renal Cell Carcinoma and Head and Neck Squamous Cell Carcinoma. The clinical trial collaboration will focus on evaluating the investigational combination in second line Renal Cell...Dragonfly has Received Milestone Payment Following Dosing of First Patient in AbbVie Phase 1 Clinical Trial Evaluating DF4101/ABBV-303
This is the eighth drug using Dragonfly's platform technology, and the sixth TriNKET® to enter into clinical trials. WALTHAM, Mass., March 5, 2024 /PRNewswire/ -- Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, today announced receipt...Dragonfly has Received Milestone Payment Following Dosing of First Patient in AbbVie Phase 1 Clinical Trial Evaluating DF4101/ABBV-303
This is the eighth drug using Dragonfly's platform technology, and the sixth TriNKET® to enter into clinical trials. WALTHAM, Mass., March 5, 2024 /PRNewswire/ -- Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, today announced receipt...
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Dragonfly Therapeutics
Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel technology to harness the body's innate immune system to bring breakthrough treatments to patients. Dragonfly has a deep pipeline of wholly-owned clinical and preclinical candidates discovered us... Read More